Literature DB >> 18254999

Targeting skeletal muscle AMP-activated protein kinase to treat type 2 diabetes.

Eric B Taylor1, Laurie J Goodyear.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18254999     DOI: 10.1007/s11892-007-0065-8

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  5 in total

Review 1.  Role of AMP-activated protein kinase in healthy and diseased hearts.

Authors:  Vernon W Dolinsky; Jason R B Dyck
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-07-14       Impact factor: 4.733

Review 2.  AMP-activated protein kinase and the regulation of glucose transport.

Authors:  Nobuharu Fujii; Niels Jessen; Laurie J Goodyear
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-07-05       Impact factor: 4.310

3.  Predominant alpha2/beta2/gamma3 AMPK activation during exercise in human skeletal muscle.

Authors:  J B Birk; J F P Wojtaszewski
Journal:  J Physiol       Date:  2006-10-12       Impact factor: 5.182

4.  Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle.

Authors:  W W Winder; B F Holmes; D S Rubink; E B Jensen; M Chen; J O Holloszy
Journal:  J Appl Physiol (1985)       Date:  2000-06

Review 5.  AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues.

Authors:  Bingzhong Xue; Barbara B Kahn
Journal:  J Physiol       Date:  2006-05-18       Impact factor: 5.182

  5 in total
  1 in total

Review 1.  Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.

Authors:  Matthias Oelze; Swenja Schuhmacher; Andreas Daiber
Journal:  Exp Diabetes Res       Date:  2010-12-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.